Article

WaveLight signs agreement with Oculus to market Oculyzer pentacam

WaveLight Inc. announced a joint agreement with German-based Oculus GmbH to sell the Oculus Pentacam under the brand name Oculyzer in conjunction with the Allegretto Wave family of products.

Chicago-WaveLight Inc. announced a joint agreement with German-based Oculus GmbH to sell the Oculus Pentacam under the brand name Oculyzer in conjunction with the Allegretto Wave family of products.

WaveLight will now offer two topography-guided systems, both of which are manufactured by Oculus. The Allegro Topolyzer produces eight reproducible topographic maps and delivers customized Allegretto Wave treatments through its T-CAT diagnostic interface. The Allegro Oculyzer features a wider array of diagnostic capabilities than the Topolyzer, including a Scheimpflug camera that provides five critical measurements of the anterior segment of the eye, as well as detailed central corneal data. It is also designed to be integrated with the Allegretto Wave through its exclusive OcuLink software interface.

The Oculyzer will be available for sale internationally in 2006, with the addition of the OcuLink anticipated in late spring. The agreement between WaveLight and Oculus will also permit the Oculyzer to be sold as a diagnostic tool for U.S. customers. While U.S. clinical studies have not been initiated using the Oculyzer, the company said it is planning to commence topography-guided clinical trials with the Topolyzer system soon.

More information is available at the WaveLight Booth 3250.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.